Beacon Consulting's time in clinical development analysis reveals that new wave ADCs spend approximately 17 months less in clinical development compared to their predecessors.
Published
Signal category
Research & Knowledge
Quote
“Beacon Consulting's time in clinical development analysis reveals that ‘new wave’ ADCs spend approximately 17 months less in clinical development compared to their predecessors.”
— Beacon team
Company
Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics.
- Industry
- Research Services
- Location
- London, GB
- Company size
- 240 employees
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape. With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Founded 2015